Lesaril Syrup

About Lesaril 1 mg/5 ml Syrup

Made by Rephco Pharmaceuticals Ltd., Lesaril is a syrup whose active ingredient is Levosalbutamol. Lesaril 1 mg/5 ml syrup is used for the treatment or prevention of bronchospasm in adults, adolescents, and children with reversible obstructive airway disease.

There are 41 brands of Levosalbutamol listed in Bangladesh. The lowest listed price is Purilin 1 mg Tablet at ৳ 0.9 per unit.

What is Lesaril 1 mg/5 ml Syrup?

The syrup Lesaril contains Levosalbutamol and is made by Rephco Pharmaceuticals Ltd. Lesaril is a syrup form of Levosalbutamol, one of the short-acting selective beta-adrenoceptor stimulants. A doctor or pharmacist can explain how this brand fits into your treatment. The dose and course are decided by the doctor.

Uses of Lesaril

Lesaril 1 mg/5 ml syrup is used for the treatment or prevention of bronchospasm in adults, adolescents, and children with reversible obstructive airway disease. Whether it is suitable for you, and how it should be used alongside other treatment, is a decision for your doctor. This inhaler is a short-acting bronchodilator, which means it helps to relax the muscles around the airways. Your doctor will decide whether it is right for you and how it fits with any other medicines you take.

How to use Lesaril

Caregivers should follow the doctor's instructions exactly and ask the pharmacist if anything is unclear. Lesaril is taken by mouth. Measure the liquid with the cap or spoon that comes with the pack. Take Lesaril 1 mg/5 ml syrups exactly as your doctor tells you. Do not change the amount or stop it without medical advice. Do not change the dose or stop using it without asking your doctor.

Side effects of Lesaril

Like all medicines, Lesaril 1 mg/5 ml syrup can cause side effects, although not everyone gets them. Low blood potassium may occur, and this can be worsened by low oxygen. Potentially serious low potassium (hypokalaemia) may result, and this effect may be made worse by hypoxia. Tell your doctor if you have any troublesome effects. Do not stop the medicine on your own.

Safety and precautions

Lesaril syrup is not for injection. If you are pregnant or breastfeeding, ask your doctor before using it, as there is limited information about its use in these situations. Levosalbutamol should be used with caution in people with heart conditions such as coronary insufficiency, high blood pressure or heart rhythm problems. Tell your doctor about all the other medicines you take.

Frequently asked questions

What does Lesaril treat?

Lesaril 1 mg/5 ml syrup is used for the treatment or prevention of bronchospasm in adults, adolescents, and children with reversible obstructive airway disease. Whether it is suitable for you, and how it should be used alongside other treatment, is a decision for your doctor.

How is Lesaril used?

Caregivers should follow the doctor's instructions exactly and ask the pharmacist if anything is unclear. Lesaril is taken by mouth.

What should I watch for while using Lesaril?

Like all medicines, Lesaril 1 mg/5 ml syrup can cause side effects, although not everyone gets them. Low blood potassium may occur, and this can be worsened by low oxygen.

Who should be careful with Lesaril?

Lesaril syrup is not for injection. If you are pregnant or breastfeeding, ask your doctor before using it, as there is limited information about its use in these situations.

Indications

Levosalbutamol Nebuliser Solution or Inhaler  is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children with reversible obstructive airway disease.

Pharmacology

Levosalbutamol Nebuliser Solution is a sterile, clear, colorless, preservative-free solution of the hydrochloride salt of Levosalbutamol, the (R)-enantiomer of the drug substance racemic salbutamol. Levosalbutamol Hydrochloride is a relatively selective β2 adrenergic receptor agonist.

Activation of β2 adrenergic receptors on airway smooth muscle leads to the activation of adenylcyclase and to an increase in the intracellular concentration of cyclic AMP. This increase in cAMP leads to the activation of protein kinase A, which inhibits the phosphorylation of myosin and lowers intracellular ionic calcium concentrations, resulting in relaxation. Levosalbutamol relaxes the smooth muscles of all airways, from the trachea to the terminal bronchioles. Levosalbutamol acts as a functional antagonist to relax the airway irrespective of the spasmogen involved, thus protecting against all bronchoconstrictor.

Dosage & Administration

Nebuliser Solution: This Nebuliser Solutions supplied in unit-dose ampoules and requires no dilution before administration by nebulization.
  • Children (6 months-11 years): The recommended dosage is 0.31 mg administered three times a day, by nebulization. Routine dosing should not exceed 0.63 mg three times a day. 
  • Adults and Adolescents above 12 years old: The recommended starting dosage is 0.63 mg administered three to four times a day, every 6 to 8 hours, by nebulization. 
  • Patients 12 years of age and older: With more severe asthma or patients who do not respond adequately: 0.63 mg of Levosalbutamol Nebuliser Solution may benefit from a dosage of 1.25 mg three times a day.
Inhaler: You should take your Levosalbutamol Inhaler as needed for an asthma attack at any time of day, with or without food, by taking 1-2 puffs up to 4 times daily and no more than 8 puffs in 24 hours. If you are using your Levosalbutamol Inhaler more than 3-4 times a week this may indicate that your asthma is not well controlled and you may need to review your medication. You can also use your Levosalbutamol Inhaler to prevent allergy or exercise induced asthma by taking 2 puffs 15 minutes before exercise or exposure to a known allergen.

Interaction

Other short-acting sympathomimetic aerosol bronchodilators or epinephrine should be used with caution with Levosalbutamol. If additional adrenergic drugs are to be administered by any route, they should be used with caution to avoid deleterious cardiovascular effects.

Beta-blockers: Beta-adrenergic receptor blocking agents not only block the pulmonary effect of beta-agonists such as Levosalbutamol Nebuliser Solution or Inhaler, but may also produce severe bronchospasm in asthmatic patients. However, under certain circumstances, e.g. prophylaxis after myocardial infarction, there may be no acceptable alternatives to the use of beta-adrenergic blocking agents in patients with asthma. In this setting, cardio selective beta-blockers could be considered with caution.

Diuretics: The ECG changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics can be acutely worsened by beta-agonists when the recommended dose of the beta-agonist is exceeded.

Digoxin: It is necessary to carefully evaluate the serum digoxin levels in patients who are currently receiving digoxin and Levosalbutamol Nebuliser Solution or Inhaler. 

Monoamine Oxidase Inhibitors or Tricyclic Antidepressants: Levosalbutamol Nebuliser Solution or Inhaler should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants, or within 2 weeks of discontinuation of such agents.

Side Effects

Potentially serious hypokalaemia may result from beta 2 - agonist therapy. This effect may be potentiated by hypoxia. Other side effects such as palpitation, fine tremors of the skeletal muscle (particularly the hand) and muscle cramps may occur. In few cases nervousness, headache, dizziness, fatigue and sleeplessness have also been reported.

Pregnancy & Lactation

Pregnancy: There are no adequate and well-controlled studies of Levosalbutamol Nebuliser Solution in pregnant women. Levosalbutamol Solution should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Lactation: It is not known whether Levosalbutamol is excreted in human milk. Caution should be exercised when Levosalbutamol Nebuliser Solution is administered to a nursing woman.

Precautions & Warnings

Levosalbutamol Hydrochloride, like all sympathomimetic amines, should be used with caution in patients with cardiovascular disorders, especially coronary insufficiency, hypertension, and cardiac arrhythmias; in patients with convulsive disorders, hyperthyroidism, or diabetes mellitus; and in patients who are unusually responsive to sympathomimetic amines. Levosalbutamol Nebuliser Solution or Inhaler must not be injected.

Overdose Effects

The expected symptoms with over dosage are those of excessive beta-adrenergic receptor stimulation and/or occurrence or exaggeration of any of the symptoms listed under side effects. Treatment consists of discontinuation of Levosalbutamol Nebuliser Solution or Inhaler together with appropriate symptomatic therapy. The judicious use of a cardioselective beta-receptor blocker may be considered.

Storage Conditions

Store below 25°C. Protect from light. Do not refrigerate.

Alternative brands of Levosalbutamol

Other brands with the same generic name, cheapest first.

See all 41 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.